Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin-bound paclitaxel + loplatin + tegafur versus docetaxel + loplatin + tegafur for perioperative advanced gastric cancer
ChiCTR2000029714Phase 4Not yet recruiting
- Sponsor
- Xijing Hospital
- Start
- Feb 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of paclitaxel, lobaplatin, tegafur and docetaxel in gastric cancer (GC) and gastric adenocarcinoma (2 arms), sponsored by Xijing Hospital. Primary endpoints: R0 resection rate, Objective response rate and 1 more. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
paclitaxellobaplatintegafurdocetaxel
03
Conditions
gastric cancer (GC)gastric adenocarcinoma
Beyond the preview
Go deeper on ChiCTR2000029714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029714.